16-10959067-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015226.3(CLEC16A):c.209+1157T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.321 in 150,914 control chromosomes in the GnomAD database, including 9,866 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.32 ( 9866 hom., cov: 30)
Consequence
CLEC16A
NM_015226.3 intron
NM_015226.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.282
Publications
6 publications found
Genes affected
CLEC16A (HGNC:29013): (C-type lectin domain containing 16A) This gene encodes a member of the C-type lectin domain containing family. Single nucleotide polymorphisms in introns of this gene have been associated with diabetes mellitus, multiple sclerosis and rheumatoid arthritis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
CLEC16A Gene-Disease associations (from GenCC):
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.571 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CLEC16A | ENST00000409790.6 | c.209+1157T>C | intron_variant | Intron 2 of 23 | 5 | NM_015226.3 | ENSP00000387122.1 | |||
| CLEC16A | ENST00000409552.4 | c.209+1157T>C | intron_variant | Intron 2 of 20 | 1 | ENSP00000386495.3 | ||||
| CLEC16A | ENST00000703130.1 | c.209+1157T>C | intron_variant | Intron 2 of 22 | ENSP00000515187.1 |
Frequencies
GnomAD3 genomes AF: 0.322 AC: 48495AN: 150796Hom.: 9864 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
48495
AN:
150796
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.321 AC: 48499AN: 150914Hom.: 9866 Cov.: 30 AF XY: 0.328 AC XY: 24192AN XY: 73742 show subpopulations
GnomAD4 genome
AF:
AC:
48499
AN:
150914
Hom.:
Cov.:
30
AF XY:
AC XY:
24192
AN XY:
73742
show subpopulations
African (AFR)
AF:
AC:
3046
AN:
40792
American (AMR)
AF:
AC:
6908
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
AC:
1012
AN:
3454
East Asian (EAS)
AF:
AC:
3029
AN:
5148
South Asian (SAS)
AF:
AC:
1376
AN:
4802
European-Finnish (FIN)
AF:
AC:
4989
AN:
10418
Middle Eastern (MID)
AF:
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
AC:
27108
AN:
67776
Other (OTH)
AF:
AC:
679
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1445
2890
4336
5781
7226
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
478
956
1434
1912
2390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1399
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.